A/Prof Daniel Utzschneider
Principal Research Fellow
Department of Microbiology and Immunology
45 Scholarly works
14 Projects
HIGHLIGHTS
2025
Journal article
Pomalidomide enhances CD8 T and NK cell mediated killing of HIV-infected cells
DOI: 10.1016/j.ebiom.2025.1060042025
Journal article
Transcriptional regulator SATB1 limits CD8 T cell population expansion and effector differentiation in chronic infection and cancer
DOI: 10.1038/s41590-025-02316-22025
Journal article
Lymph nodes fuel KLF2-dependent effector CD8 T cell differentiation during chronic infection and checkpoint blockade
DOI: 10.1038/s41590-025-02276-72025
Journal article
Lymph-node-derived stem-like but not tumor-tissue-resident CD8 T cells fuel anticancer immunity
DOI: 10.1038/s41590-025-02219-22024
Research grants (other domestic)
Developing the Next Generation of Immunotherapies to Cure Cancer
2024
Research grants (ARC, NHMRC, MRFF)
Deciphering the Immune Complexity That Orchestrates T Cell Activation
2021
Research grants (ARC, NHMRC, MRFF)
Characterization and Targeting of Precursor Exhausted T Cells (TPEX) for the Treatment of Chronic Infection and Cancer
RECENT SCHOLARLY WORKS
2025
Journal article
Splenic fibroblastic reticular cells orchestrate dendritic cell maturation and facilitate CD8 T cell priming and protective memory
DOI: 10.1126/sciadv.adt59392025
Journal article
Nutrient metabolism shapes epigenetic landscape of T cells: Immunometabolism
DOI: 10.1038/s41590-025-02080-32025
Journal article
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
DOI: 10.1126/sciimmunol.adn19452024
Journal article
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia
DOI: 10.1182/blood.20240243412024
Journal article
Mouse guanylate-binding proteins of the chromosome 3 cluster do not mediate antiviral activity in vitro or in mouse models of infection
DOI: 10.1038/s42003-024-06748-82024
Journal article
Aerobic glycolysis but not GLS1-dependent glutamine metabolism is critical for anti-tumor immunity and response to checkpoint inhibition.
DOI: 10.1016/j.celrep.2024.114632
RECENT PROJECTS
2025
Research grants (international)
Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression
2026
Research grants (ARC, NHMRC, MRFF)
Understanding Drivers of T Cell Stemness